Human IGFBP-3 Quantikine ELISA Kit
| Name | Human IGFBP-3 Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DGB300 |
| Category | ELISA Kit |
| Prices | $479.00, $2,290.00, $15,560.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL) |
| Sensitivity | 0.14 ng/mL |
| Range | 0.8 - 50 ng/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human IGFBP-3 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human IGFBP-3 in cell culture supernates, serum, and plasma |
| Gene | IGFBP3 |
| Supplier Page | Shop |
Product images
Product References
CD44 expression in endothelial colony-forming cells regulates neurovascular - CD44 expression in endothelial colony-forming cells regulates neurovascular
Sakimoto S, Marchetti V, Aguilar E, Lee K, Usui Y, Murinello S, Bucher F, Trombley JK, Fallon R, Wagey R, Peters C, Scheppke EL, Westenskow PD, Friedlander M. JCI Insight. 2017 Jan 26;2(2):e89906.
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. - IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
Svalina MN, Kikuchi K, Abraham J, Lal S, Davare MA, Settelmeyer TP, Young MC, Peckham JL, Cho YJ, Michalek JE, Hernandez BS, Berlow NE, Jackson M, Guillaume DJ, Selden NR, Bigner DD, Nazemi KJ, Green SC, Corless CL, Gultekin S, Mansoor A, Rubin BP, Woltjer R, Keller C. Sci Rep. 2016 Jun 3;6:27012.
Genetic variation in IGF1 predicts renal cell carcinoma susceptibility and - Genetic variation in IGF1 predicts renal cell carcinoma susceptibility and
Cao Q, Liang C, Xue J, Li P, Li J, Wang M, Zhang Z, Qin C, Lu Q, Hua L, Shao P, Wang Z. Sci Rep. 2016 Dec 15;6:39014.
The Differential Hormonal Milieu of Morning versus Evening May Have an Impact on - The Differential Hormonal Milieu of Morning versus Evening May Have an Impact on
Burley SD, Whittingham-Dowd J, Allen J, Grosset JF, Onambele-Pearson GL. PLoS One. 2016 Sep 1;11(9):e0161500.
Effects of exercise and milk fat globule membrane (MFGM) supplementation on body - Effects of exercise and milk fat globule membrane (MFGM) supplementation on body
Kim H, Suzuki T, Kim M, Kojima N, Ota N, Shimotoyodome A, Hase T, Hosoi E, Yoshida H. PLoS One. 2015 Feb 6;10(2):e0116256.
Glucose intolerance in aging male IGFBP-3 transgenic mice: differential effects - Glucose intolerance in aging male IGFBP-3 transgenic mice: differential effects
Nguyen KH, Yao XH, Erickson AG, Mishra S, Nyomba BL. Endocrinology. 2015 Feb;156(2):462-74.
Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells - Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells
Choi YJ, Park GM, Rho JK, Kim SY, So GS, Kim HR, Choi CM, Lee JC. PLoS One. 2013 Dec 5;8(12):e81393.
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary - Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary
Braicu EI, Fotopoulou C, Chekerov R, Richter R, Blohmer J, Kummel S, Stamatian F, Yalcinkaya I, Mentze M, Lichtenegger W, Sehouli J. Cytokine. 2013 Mar;61(3):755-8.
Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic - Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic
Higgins MF, Russell NE, Crossey PA, Nyhan KC, Brazil DP, McAuliffe FM. PLoS One. 2012;7(2):e29164.
Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 - Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3
Elzi DJ, Lai Y, Song M, Hakala K, Weintraub ST, Shiio Y. Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12052-7. doi: